Stockscreener 앱 받기
9.81
4.29%
-0.44
Rapt Therapeutics Inc 주식(RAPT)의 최신 뉴스
Understanding RAPT Therapeutics Inc.’s price movementFree Watchlist for Smart Swing Trading - Newser
Ranking RAPT Therapeutics Inc. among high performing stocks via toolsSmart Swing Picks with Confirmed Signals - Newser
Has RAPT Therapeutics Inc. formed a bullish divergenceShort-Term Market Movement Forecast Report - Newser
Sentiment analysis tools applied to RAPT Therapeutics Inc.Predictive System for Long-Term Stock Forecast - Newser
How to forecast RAPT Therapeutics Inc. trends using time seriesProfit Target Planning with Exit Confidence - Newser
Multi asset correlation models including RAPT Therapeutics Inc.Technical Insight Guide for Safer Trades - Newser
Applying Elliott Wave Theory to RAPT Therapeutics Inc.Buy and Hold Position Summary Review - Newser
Published on: 2025-08-09 04:24:12 - beatles.ru
Using AI based signals to follow RAPT Therapeutics Inc.Stock Entry Point Planner with Volume Spike - Newser
Using Ichimoku Cloud for RAPT Therapeutics Inc. technicalsAlpha Stock Picks with Chart Confirmation - Newser
Will RAPT Therapeutics Inc. continue its uptrendCapital Growth Summary Over Five Years - Newser
RAPT Therapeutics Inc. stock daily chart insightsTrade Setup Builder with Custom Alerts - Newser
Volume spikes in RAPT Therapeutics Inc. stock – what they meanTrade Setup Builder with Custom Alerts - Newser
Historical volatility pattern of RAPT Therapeutics Inc. visualizedScalable Strategy with Chart Confirmation - Newser
Analyzing drawdowns of RAPT Therapeutics Inc. with statistical toolsTechnical Long-Term Outlook and Recap Guide - Newser
RAPT Therapeutics Reports Q2 2025 Financial Results: Net Loss of $34.8 Million, Cash and Securities Valued at $169 Million. - AInvest
Full technical analysis of RAPT Therapeutics Inc. stockAlpha Trade Flow With Risk Calibration - Newser
Wells Fargo lowers Rapt Therapeutics stock price target to $38 on model changes - Investing.com Canada
Rapt Therapeutics’ Reverse Stock Split: Potential Pitfalls and Market Challenges - TipRanks
RAPT Therapeutics Reports Q2 2025 Financial Results - TipRanks
Why RAPT Therapeutics Inc. stock attracts strong analyst attentionFree Capital Growth With Controlled Risk Picks - Newser
RAPT Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Rapt Therapeutics reports Q2 EPS (65c), consensus (65c) - TipRanks
RAPT Therapeutics, Inc. SEC 10-Q Report - TradingView
RAPT Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewswire
RAPT Therapeutics Q2 revenue up 16% YoY to $7.5mln. - AInvest
RAPT Therapeutics Slashes Losses by $10M, Preps Major Food Allergy Trial Launch - Stock Titan
What machine learning models say about RAPT Therapeutics Inc.Real-Time Signal Tracking with Entry Level - Newser
Clear Street raises Rapt Therapeutics stock price target to $24 on RPT904 potential - Investing.com Canada
Rapt Therapeutics (RAPT) Expected to Announce Quarterly Earnings on Thursday - Defense World
Building trade automation scripts for RAPT Therapeutics Inc.Trade Alert System with Volume Analysis - Newser
Applying sector rotation models to RAPT Therapeutics Inc.High Reward Investment Strategy for Beginners - Newser
RAPT Therapeutics Inc. Pullback Analyzed — Is It Time to ExitEarly Breakout Entry Point Notifications Sent - beatles.ru
0.24%
3.39%
자본화:
|
볼륨(24시간):